TGFB1 and pulmonary emphysema: Via CRISPR/Cas-9 targeted deletion, we then demonstrated that a ~ 100 bp segment containing rs1690789 increases TGFB2 expression in primary human lung fibroblasts, providing novel evidence that genetic variation affecting TGF-β signaling contributes to the genetic predisposition to emphysema.